(:CHFS)

May 17, 2021 08:00 am ET
ACC 2021 Presentation Adds to Body of Evidence Supporting Nuwellis Ultrafiltration to Treat Patients with Heart Failure
Data supporting the effectiveness of Aquadex FlexFlow® system in the treatment of acutely decompensated heart failure (ADHF) patients was presented May 16th at the 2021 American College of Cardiology conference (ACC). The single-center study...
May 13, 2021 08:45 am ET
Nuwellis Provides More Children in Texas With Access to Its Unique Fluid Management Technology
Reaffirming its commitment to expanding access to life-saving ultrafiltration therapies for adult and pediatric patients suffering from fluid overload, Nuwellis, Inc. (Nasdaq: NUWE), formerly CHF Solutions, Inc., today announced that its Aquadex...
May 11, 2021 08:00 am ET
Nuwellis, Inc. Announces 18 Percent Increase in Revenue for First Quarter 2021 Over Previous Year and Provides Company Update
Nuwellis, Inc. (Nasdaq: NUWE) (previously CHF Solutions, Inc.) announced today its results for the first quarter ended March 31, 2021, which included the following highlights: Completed corporate rebranding from CHF...
Apr 29, 2021 04:05 pm ET
Nuwellis, Inc. To Announce First Quarter 2021 Financial Results on May 11, 2021
Nuwellis, Inc. (NASDAQ:NUWE), formally CHF Solutions, announces today that its first quarter 2021 financial results will be released on Tuesday, May 11, 2021. The company will host a conference call and webcast at 9:00 AM ET, during which...
Apr 27, 2021 09:00 am ET
CHF Solutions Expands Commercial Focus, Changes Name to Nuwellis
Company names are reflective of the services provided to its customers, and CHF Solutions – a leader and pioneer in the heart failure space – has evolved to serve more than just the chronic heart failure community. The company today announced it is...
Apr 23, 2021 08:00 am ET
CHF Solutions Expands Access to Ultrafiltration Therapy for Pediatric Patients in Two Texas Hospitals
Improving access to life-saving fluid management therapies is a commitment CHF Solutions (Nasdaq: CHFS) stands by. The company today announced Aquadex SmartFlow® is now available at two new pediatric hospitals in Texas. CHF Solutions is a medical...
Apr 20, 2021 08:00 am ET
CHF Solutions Announces First Patient Enrolled in the ULTRA-Peds Registry
More pediatric clinical evidence is essential in understanding the real-world benefits of medical devices in children. CHF Solutions is committed to expanding pediatric-specific data, and today announced Joe DiMaggio Children’s Hospital in...
Apr 08, 2021 08:00 am ET
The Portability of Aquadex SmartFlow® from CHF Solutions Could Mean More Critically-Ill Patients Have Access to Life-Saving Ultrafiltration Therapy
Bringing transportable care directly to patients who are too critically-ill to be moved could be the difference between life and death. New evidence demonstrates that ultrafiltration therapy (aquapheresis) using the Aquadex SmartFlow® system by CHF...
Mar 19, 2021 12:03 pm ET
CHF Solutions, Inc. Announces Closing of $20.9 Million Underwritten Public Offering of Common Stock Including Full Exercise of Over-Allotment Option
CHF Solutions, Inc. (NASDAQ:CHFS) (the “Company”) today announced the closing of its previously announced underwritten public offering of 3,795,816 shares of its common stock at a price to the public of $5.50 per share, for gross proceeds of...
Mar 17, 2021 08:30 am ET
CHF Solutions, Inc. Announces Pricing of $18.1 Million Underwritten Public Offering of Common Stock
CHF Solutions, Inc. (NASDAQ:CHFS) (the “Company”) today announced the pricing of an underwritten public offering of 3,300,710 shares of its common stock at a price to the public of $5.50 per share, for gross proceeds of approximately $18.1 million...
Mar 16, 2021 04:05 pm ET
CHF Solutions, Inc. Announces Proposed Underwritten Public Offering of Common Stock
CHF Solutions, Inc. (NASDAQ:CHFS) (the “Company”) announced today that it intends to offer shares of its common stock in an underwritten public offering.  All of the shares of common stock to be sold in the offering will be offered by the Company....
Mar 11, 2021 08:00 am ET
CHF Solutions Submits Patent Application for New Peripheral Venous Access Technology for Ultrafiltration and CRRT Systems
CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, today announced the submission of a patent application for a system to dramatically improve and simplify venous access...
Mar 09, 2021 08:00 am ET
CHF Solutions Expands Access to Ultrafiltration Therapy for Pediatric Patients in Puerto Rico
CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, today announced its Aquadex SmartFlow® system is now available for the treatment of fluid overloaded pediatric...
Mar 05, 2021 05:00 pm ET
CHF Solutions, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
CHF Solutions, Inc. (NASDAQ: CHFS), today announced that, effective February 17, 2021, the independent directors approved one equity award under CHF Solution’s New-Hire Equity Incentive Plan, as material inducement to an individual entering into...
Mar 04, 2021 08:00 am ET
ERAS 2021: CHF Solutions to Host On-Demand Presentation on Management of Fluid Overload in Cardiac Surgery Patients
CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, will participate in the first ERAS Cardiac Society Virtual Conference, broadcasting Live from Methodist Hospital...
Mar 02, 2021 08:00 am ET
CHF Solutions, Inc. Announces 49.5 Percent Increase in Revenue for Fourth Quarter 2020 and Provides Company Update
CHF Solutions, Inc. (Nasdaq: CHFS) announced today its results for the fourth quarter ended December 31, 2020. Recent Highlights Revenue for the fourth quarter of 2020 was $2 million, an increase of 49.5% compared to the prior year periodGross...
Feb 16, 2021 08:00 am ET
CHF Solutions, Inc. To Announce Fourth Quarter 2020 Financial Results on March 2, 2021
CHF Solutions, Inc. (NASDAQ: CHFS) announces today that its fourth quarter 2020 financial results will be released on Tuesday, March 2, 2021. The company will host a conference call and webcast at 9:00 AM ET that morning, during which management...
Feb 03, 2021 08:00 am ET
CHF Solutions Submits Patent Application for New and Improved Diagnostic Parameters to Support Hemodynamic Stability
CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, today announced the submission of a patent application to increase monitoring capabilities with its Aquadex SmartFlow™...
Jan 28, 2021 08:00 am ET
CHF Solutions’ Physician-Led Webinar Highlights Real-World Evidence Supporting Effectiveness of Ultrafiltration in Heart Failure Patients
CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, today announced key takeaways from its physician-led webinar discussing real-world experience using ultrafiltration...
Jan 21, 2021 08:00 am ET
CHF Solutions Offers Educational Event on Effective Fluid Management Strategies in Heart Failure Patients
CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, today announced the company will host an interactive, physician-led webinar to discuss “Real-World Experience Using...
Jan 19, 2021 08:00 am ET
CHF Solutions Appoints Nestor Jaramillo, Jr. as President and Chief Executive Officer
CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, today announced the appointment of President and Chief Operating Officer Nestor Jaramillo, Jr. to President and Chief...
Jan 12, 2021 08:00 am ET
CHF Solutions Protects New Peripheral Vascular Access Catheter with Patent Application
CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, today announced the submission of a patent application for a peripheral vascular access catheter for use with its...
Dec 15, 2020 08:00 am ET
CHF Solutions Announces Meta-Analysis Demonstrates Ultrafiltration is Better than Diuretic Therapy for the Management of Volume Overload in ADHF
CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, today announced a meta-analysis published in Heart Failure Reviews concludes that ultrafiltration (UF) increases fluid...
Dec 04, 2020 08:00 am ET
CHF Solutions Announces Webinar on Pediatric Ultrafiltration Therapy hosted by Ladenburg Thalman & Co.
CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, today announced that Ladenburg Thalman & Co. will host a conference call and webcast at 1:00p.m. Eastern Time on...
Nov 23, 2020 05:41 pm ET
CHF Solutions, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
CHF Solutions, Inc. (NASDAQ: CHFS), today announced that, effective November 16, 2020, the independent directors approved three equity awards under CHF Solution’s New-Hire Equity Incentive Plan, as material inducements to three individuals entering...
Nov 10, 2020 08:00 am ET
CHF Solutions, Inc. Announces 52 Percent Increase in Revenue for Third Quarter 2020 and Provides Company Update
CHF Solutions, Inc. (Nasdaq: CHFS) announced today its results for the third quarter ended September 30, 2020. Recent Highlights Revenue for the third quarter of 2020 was $1.9 million, an increase of 52% compared to the prior year periodIncreased...
Nov 03, 2020 08:00 am ET
CHF Solutions, Inc. To Announce Third Quarter 2020 Financial Results on November 10, 2020
CHF Solutions, Inc. (NASDAQ: CHFS) announces today that its third quarter 2020 financial results will be released on Tuesday, November 10, 2020. The company will host a conference call and webcast at 9:00 AM ET that morning, during which management...
Oct 29, 2020 08:00 am ET
CHF Solutions Announces First Commercial Shipments of Aquadex Systems to Brazil, following Regulatory Approval
CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, today announced it has shipped the first commercial orders of its Aquadex SmartFlow™ system to Brazil, following...
Oct 27, 2020 08:00 am ET
CHF Solutions Announces Deployment of Aquadex Systems to Hospitals in the Southeast to Treat COVID-19 Patients
CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, today announced that it has shipped Aquadex™ product to medical facilities in Tennessee and South Carolina to treat...
Oct 23, 2020 08:00 am ET
CHF Solutions Submits Patent Application to Improve Venous Blood Flow and Ultrafiltration Efficiency
CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, today announced the submission of a patent application for a new technological advance to the Aquadex SmartFlow™...
Oct 07, 2020 08:00 am ET
CHF Solutions Announces Data Demonstrating Benefit of Aquadex Therapy for Treatment of Heart Failure and COVID-19
CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, today announced data from a retrospective study and a case study supporting the benefit of Aquadex™ therapy in the...
Sep 30, 2020 08:00 am ET
CHF Solutions Initiatives at HFSA 24th Annual Scientific Meeting Highlight Aquadex Therapy Performance in Heart Failure
CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, today announced its initiatives for the 24th Annual Scientific Meeting of the Heart Failure Society of America (HFSA)...
Sep 23, 2020 08:00 am ET
CHF Solutions to Share COVID-19 Experience with Leading Government Commission
CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to improving the lives of patients suffering from fluid overload conditions, today announced it will be providing testimony to the U.S. International Trade Commission (USITC)...
Sep 11, 2020 09:15 am ET
CHF Solutions to Participate at Lake Street Capital Markets’ 4th Annual BIG4 Conference on September 17, 2020
CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, today announced the company will participate in Lake Street Capital Markets’ 4th Annual Best Ideas Growth Conference,...
Sep 10, 2020 09:15 am ET
CHF Solutions’ Physician-Led Webinar Concludes Fluid Overloaded Heart Failure Patients Benefit from Ultrafiltration
CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, today announced key takeaways from a recent webinar, where Dr. John L. Jefferies discussed the use of precision...
Sep 03, 2020 08:00 am ET
CHF Solutions Continues Physician-Led Webinar Series Discussing Precise Management of Fluid Overload in Patients with Acute Heart Failure
CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, today announced the company will host an interactive, physician-led webinar to discuss “Precision Medicine for the...
Sep 01, 2020 08:00 am ET
CHF Solutions Receives 180-Day Extension to Meet Nasdaq Minimum Bid Price Requirement
CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, announced today receipt of written notification from the Nasdaq Stock Market that it has granted the company’s request...
Aug 27, 2020 08:15 am ET
CHF Solutions Applauds U.S Congress Request to U.S. International Trade Commission to Identify Products to Treat COVID-19
CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to improving the lives of patients suffering from fluid overload, today commended a request from the U.S. Congress to the U.S. International Trade Commission (USITC) concerning the...
Aug 21, 2020 04:15 pm ET
CHF Solutions, Inc. Announces Closing of $14.37 Million Underwritten Public Offering and Full Exercise of Over-Allotment Option
CHF Solutions, Inc. (NASDAQ:CHFS) today announced the closing of an underwritten public offering of units for gross proceeds of approximately $14.37 million, which includes the full exercise of the underwriter's over-allotment option to purchase...
Aug 19, 2020 08:30 am ET
CHF Solutions, Inc. Announces Pricing of $12.5 Million Underwritten Public Offering
CHF Solutions, Inc. (NASDAQ:CHFS), a medical device company dedicated to improving the lives of patients suffering from fluid overload, today announced the pricing of an underwritten public offering of units for gross proceeds of approximately...
Aug 18, 2020 08:00 am ET
CHF Solutions’ Aquadex Products Granted Federal Supply Schedule Contract
CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to improving the lives of patients suffering from fluid overload, today announced that its Aquadex™ product line has been added to the Federal Supply Schedule, expanding access to all...
Aug 04, 2020 09:31 am ET
Thinking about buying stock in Sonnet BioTherapeutics, CHF Solutions, Harmonic Inc, Tiziana Life Sciences, or Seanergy Maritime Holdings?
NEW YORK, Aug. 4, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for SONN, CHFS, HLIT, TLSA, and SHIP.
Aug 04, 2020 08:00 am ET
CHF Solutions, Inc. Announces 14 Percent Increase in Revenue for Second Quarter 2020 Over Previous Quarter and Provides Company Update
CHF Solutions, Inc. (Nasdaq: CHFS) announced today its results for the second quarter ended June 30, 2020, which included the following highlights: Revenue for the second quarter ended June 30, 2020, was $1.9 million, an increase of 14 percent...
Jul 30, 2020 08:00 am ET
CHF Solutions Further Expands Commercial Presence in the Middle East with Distribution Arrangement for Israel and Palestine
CHF Solutions (Nasdaq: CHFS) today announced the signing of a distribution agreement with SysteMedic Ltd., covering Israel and Palestine, representing the second distribution partnership in the Middle East region.  Ultrafiltration therapy is now...
Jul 28, 2020 08:00 am ET
CHF Solutions, Inc. To Announce Second Quarter 2020 Financial Results on August 4, 2020
CHF Solutions, Inc. (NASDAQ: CHFS) announces today that its second quarter 2020 financial results will be released on Tuesday, August 4, 2020. The company will host a conference call and webcast at 9:00 AM ET that morning, during which management...
Jul 16, 2020 08:00 am ET
CHF Solutions Announces Registry for Fluid Overload Conditions in Pediatric Patients
CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to improving the lives of patients suffering from fluid overload, today announced the development of a pediatric registry through a partnership with the Acute Kidney Injury Critical...
Jul 14, 2020 08:00 am ET
CHF Solutions Continues Physician-Led Webinar Series with Focus on Treatment of Fluid Overload in Pediatric Patients
CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to improving the lives of patients suffering from fluid overload, today announced key takeaways from a recent webinar where David Askenazi, M.D. MSPH shared his experience and...
Jul 08, 2020 09:25 am ET
CHF Solutions and RenalSense Enter Distribution Partnership to Offer Ultrafiltration and Real-Time Renal Diagnostics
CHF Solutions (Nasdaq: CHFS) and RenalSense, Ltd., today announced the signing of a distribution agreement to offer complementary solutions for fluid management. The agreement allows CHF Solutions to market and sell RenalSense’s Clarity RMS™...
Jun 25, 2020 08:30 am ET
CHF Solutions Promotes Nestor Jaramillo, Jr. to President and Chief Operating Officer
CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to improving the lives of patients suffering from fluid overload, today announced the promotion of Nestor Jaramillo, Jr. to President and Chief Operating Officer, effective July 1,...
Jun 23, 2020 08:00 am ET
CHF Solutions to Host Webinar Discussing Treatment of Fluid Overload in Pediatric Patients
CHF Solutions (Nasdaq: CHFS) today announced the company will host an interactive, physician-led webinar to discuss treatment of fluid overload in pediatric patients greater than 20 kg. Registration is open for the webinar, which will be led by Dr....
Jun 18, 2020 09:29 am ET
Clinical Experts Discuss Fluid Management Strategies in Critically Ill COVID-19 Patients during CHF Solutions Webinar
CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to improving the lives of patients suffering from fluid overload, announces key conclusions from yesterday’s webinar during which experts in fluid management and critical care...
Jun 12, 2020 08:00 am ET
CHF Solutions to Host Webinar Discussing Fluid Management Strategies in Critically Ill COVID-19 Patients
CHF Solutions (Nasdaq: CHFS) today announced the company will host an interactive, physician-led webinar to discuss the recent publication: SARS-CoV-2 (COVID-19) and intravascular volume management strategies in the critically ill.1 and the role of...
Jun 11, 2020 08:00 am ET
CHF Solutions Ships Aquadex SmartFlow Products to Florida for Use with COVID-19 Patients
CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, today announced that it has sold Aquadex SmartFlow™ consoles and disposables to a critical care hospital for use in...
Jun 04, 2020 08:00 am ET
CHF Solutions Announces the Launch of Pediatric Ultrafiltration Therapy Using the Aquadex SmartFlow System at Children’s Hospital of The King’s Daughters
CHF Solutions (Nasdaq: CHFS) today announced Children’s Hospital of The King’s Daughters (CHKD) in Norfolk, Virginia has initiated ultrafiltration therapy using the Aquadex SmartFlow™ system. “Following FDA clearance and the launch of the...
May 28, 2020 08:00 am ET
CHF Solutions Expands Commercial Presence in the Middle East with Distribution Arrangement for United Arab Emirates
CHF Solutions (Nasdaq: CHFS) today announced the signing of a distribution agreement with Transimed Medical Equipment Co. LLC covering the United Arab Emirates, the first distribution partnership in the Middle East region. The company now has...
May 22, 2020 04:35 pm ET
CHF Solutions, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
CHF Solutions, Inc. (NASDAQ: CHFS), today announced that, on May 20, 2020, the independent directors approved six equity awards under CHF Solution’s New-Hire Equity Incentive Plan, as material inducements to six individuals entering into employment...
May 22, 2020 04:30 pm ET
CHF Solutions, Inc. Announces Adjournment of Annual Meeting of Stockholders
CHF Solutions, Inc. (Nasdaq:CHFS) (“CHF Solutions”) today announced that its 2020 Annual Meeting of Stockholders held on May 20, 2020 convened and then adjourned until June 19, 2020 2:00 p.m. US Central Time at https://web.lumiagm.com/257409059 to...
May 20, 2020 08:00 am ET
Publication Highlights Use of Ultrafiltration for Fluid Management in COVID-19 Patients
CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, today announced a publication highlighting the use of ultrafiltration for fluid management of critically ill patients...
May 12, 2020 08:00 am ET
CHF Solutions, Inc. Announces 34 Percent Increase in Revenue for First Quarter 2020 Over Previous Year and Provides Company Update
CHF Solutions, Inc. (Nasdaq: CHFS) announced today its results for the first quarter ended March 31, 2020, which included the following highlights: Revenue for the first quarter ended March 31, 2020, was $1.6 million, an increase of 34 percent...
May 05, 2020 08:00 am ET
CHF Solutions, Inc. to Announce First Quarter 2020 Financial Results on May 12, 2020
CHF Solutions, Inc. (NASDAQ: CHFS) announces today that its first quarter 2020 financial results will be released on Tuesday, May 12, 2020. The company will host a conference call and webcast at 9:00 AM ET that morning, during which management will...
May 01, 2020 01:40 pm ET
CHF Solutions, Inc. Announces Registered Direct Offering Priced At-the-Market
CHF Solutions (CHFS) today announced the pricing of a registered direct offering of 3,597,880 shares of its common stock at a price of $0.4725 per share, for gross proceeds of approximately $1.7 million, prior to deduction of commissions and...
May 01, 2020 08:00 am ET
CHF Solutions Ships Aquadex Product to COVID-19 Specialty Center in Minnesota
CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, today announced that it has shipped Aquadex product to a specialty care center designated for the most severe COVID-19...
Apr 23, 2020 08:00 am ET
CHF Solutions Ships First Commercial Orders of Aquadex SmartFlow™ system to Austria
CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, today announced that it has shipped the first commercial orders of its next generation Aquadex SmartFlow™ system to...
Apr 21, 2020 08:00 am ET
CHF Solutions Receives $1.66 Million under SBA’s Paycheck Protection Program and $1.1 Million from Warrant Exercises
CHF Solutions (Nasdaq: CHFS), a small and growing medical device company dedicated to changing the lives of patients suffering from fluid overload, announced receipt of $1.66 million under the Paycheck Protection Program (PPP) under the federal...
Apr 16, 2020 09:00 am ET
CHF Solutions Announces 300% Increase in Utilization of Aquadex Therapy in NYC Hospitals, the Epicenter of COVID-19
CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, announced increased utilization of its Aquadex therapy in patients affected by COVID-19. Product sales of the Aquadex...
Apr 14, 2020 08:00 am ET
CHF Solutions Announces COVID-19 Patients Treated with Aquadex Therapy for Fluid Management When Access to Dialysis Machines is Limited or Not Available
CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, announced that physicians on the frontlines of treating patients with COVID-19 have used Aquadex therapy for patients...
Apr 09, 2020 08:00 am ET
CHF Solutions Submits Patent Application for Hemofiltration System for Rapid Clearing of Cytokines in COVID-19 patients
CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, today announced the submission of a patent application for an adaptation to the Aquadex SmartFlow™ system to rapidly...
Apr 08, 2020 09:15 am ET
CHF Solutions Convene Physicians to Discuss Cardio-Pulmonary-Renal Management of COVID-19 Patients
CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, today announced the company will host an interactive, clinician-led webinar to discuss cardio-pulmonary-renal...
Apr 02, 2020 08:00 am ET
CHF Solutions Doubles Production Staff of Aquadex SmartFlow™ Consoles Due to Hospital Demand
CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, announced that it has doubled the production staff that builds its next generation Aquadex SmartFlow consoles in...
Mar 30, 2020 09:26 am ET
CHF Solutions, Inc. Announces Pricing of Registered Direct Offering Priced At-the-Market
CHF Solutions (Nasdaq: CHFS) today announced the pricing of a registered direct offering of 5,130,228 shares of its common stock at a price to the public of $0.434 per share, for gross proceeds of approximately $2,226,000, prior to deduction of...
Mar 25, 2020 08:00 am ET
CHF Solutions Announces COVID-19 Patients Treated with Aquadex Therapy for Fluid Management
CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, announced the use of its Aquadex therapy in the treatment of patients infected with the coronavirus COVID-19. In the...
Mar 20, 2020 08:30 am ET
CHF Solutions, Inc. Announces Pricing of Registered Direct Offering
CHF Solutions (Nasdaq: CHFS) today announced the pricing of a registered direct offering of 4,161,392 shares of its common stock at a price to the public of $0.30 per share, for gross proceeds of approximately $1,248,000, prior to deduction of...
Mar 19, 2020 08:00 am ET
CHF Solutions’ Aquadex FlexFlow® System is licensed and approved for sale in India
CHF Solutions (Nasdaq: CHFS) today announced the Aquadex FlexFlow system has been licensed and approved for sale in India, making ultrafiltration therapy available for patients suffering from hypervolemia, or fluid overload, in one of the largest...
Mar 18, 2020 08:00 am ET
CHF Solutions Webinar Highlighted Importance of Fluid Management in Patients Treated for COVID-19
CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to improving the lives of patients suffering from fluid overload, announced the key takeaways from its clinician webinar held yesterday, which stressed the importance of managing...
Mar 13, 2020 08:00 am ET
CHF Solutions to Host Clinician Webinar on Use of Ultrafiltration for Volume Management in Patients Treated for COVID-19
CHF Solutions (Nasdaq: CHFS) today announced the company will host an interactive, physician-led webinar to discuss the importance of volume management in the treatment of patients with COVID-19.  Dr. Amir Kazory will moderate the discussion on...
Mar 03, 2020 08:00 am ET
CHF Solutions, Inc. Announces Fourth Quarter Financial Results and Provides Company Update
CHF Solutions, Inc. (Nasdaq: CHFS) announced today its results for the fourth quarter and year ended December 31, 2019, which included the following highlights: Received 510(k) clearance in the U.S. and CE Mark in the EU for adult and pediatric...
Feb 26, 2020 08:00 am ET
CHF Solutions receives 510(k) clearance for Aquadex SmartFlow™ system in Pediatric Patients Weighing 20kg or More
CHF Solutions (Nasdaq: CHFS) today announced FDA 510(k) clearance in the U.S. of its next generation Aquadex SmartFlow console for use in adult and pediatric patients who weigh 20kg or more. The console is a simple, gentle, and smart solution for...
Feb 25, 2020 08:00 am ET
CHF Solutions, Inc. To Announce Fourth Quarter and Year-End 2019 Financial Results on March 3, 2020
CHF Solutions, Inc. (NASDAQ: CHFS) announces today that its fourth quarter and year-end 2019 financial results will be released on Tuesday, March 3, 2020. The company will host a conference call and webcast at 9:00 AM ET that morning, during which...
Feb 12, 2020 09:15 am ET
CHF Solutions Expands Commercial Presence in Europe with Distribution Arrangement for Germany, Austria and Switzerland
CHF Solutions (Nasdaq: CHFS) today announced the initiation of distribution agreements covering Germany, Austria and Switzerland with Neucomed Group and its affiliates, further expanding its commercial presence in the European Union. The company...
Feb 11, 2020 04:45 pm ET
CHF Solutions, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
CHF Solutions, Inc. (NASDAQ: CHFS), today announced that, on February 5, 2020, the independent directors approved five equity awards under CHF Solution’s New-Hire Equity Incentive Plan, as material inducements to five individuals entering into...
Feb 05, 2020 08:00 am ET
CHF Solutions Receives CE Mark for its New Aquadex SmartFlow™ Console
CHF Solutions (Nasdaq: CHFS) today announced the receipt of a CE Mark for its Aquadex SmartFlow console, its next generation ultrafiltration system. The console is a simple, flexible and smart solution for treatment of patients suffering from fluid...
Jan 30, 2020 08:00 am ET
CHF Solutions Expands its Patent Portfolio with Four Applications for Innovations for Aquapheresis Therapy
CHF Solutions (Nasdaq: CHFS) today announced the filing of four patent applications with the United States Patent and Trademark Office (USPTO) to protect new innovations for use in aquapheresis therapy and further strengthen the company’s...
Jan 28, 2020 04:10 pm ET
CHF Solutions, Inc. Announces Closing of $9.66 Million Underwritten Public Offering and Full Exercise of Over-Allotment Option
CHF Solutions, Inc. (NASDAQ:CHFS) today announced the closing of an underwritten public offering of units for gross proceeds of approximately $9.66 million, which includes the full exercise of the underwriter's over-allotment option to purchase...
Jan 24, 2020 09:37 am ET
CHF Solutions, Inc. Announces Pricing of $8.4 Million Underwritten Public Offering
CHF Solutions, Inc. (NASDAQ:CHFS) today announced the pricing of an underwritten public offering of units for gross proceeds of approximately $8.4 million prior to deducting underwriting discounts and commissions and offering expenses payable by...
Jan 22, 2020 08:00 am ET
CHF Solutions Announces Launch of Aquapheresis Therapy Using Aquadex FlexFlow® System at the Baylor Scott & White Health System in Texas
CHF Solutions (Nasdaq: CHFS) today announced that Texas-based health system, Baylor Scott & White Health has initiated offering aquapheresis therapy using the company’s Aquadex FlexFlow® system at its Baylor Scott & White Medical Center in Temple,...
Jan 08, 2020 08:00 am ET
CHF Solutions Announces Presentation of Clinical Data with Aquadex FlexFlow® Highlighting Efficacy and Simplicity of Use In Treating Critical Care Patients
CHF Solutions (Nasdaq: CHFS) today announced results from an investigator-initiated retrospective analysis of utilization of the Aquadex FlexFlow aquapheresis system at Lenox Hill Hospital in New York City. The study was presented at the American...
Dec 03, 2019 08:00 am ET
CHF Solutions Announces Launch of Ultrafiltration Therapy Using Aquadex FlexFlow® System at Memphis Methodist Le Bonheur Healthcare System
CHF Solutions (Nasdaq: CHFS) today announced that Memphis, Tennessee-based health system, Methodist Le Bonheur, has initiated offering aquapheresis therapy to patients suffering from fluid overload using the company’s Aquadex FlexFlow system. The...
Nov 15, 2019 05:30 pm ET
CHF Solutions, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
CHF Solutions, Inc. (NASDAQ: CHFS), today announced that, on November 12, 2019, the independent directors approved eight equity awards under CHF Solution’s New-Hire Equity Incentive Plan, as material inducements to eight individuals entering into...
Nov 05, 2019 08:00 am ET
CHF Solutions, Inc. Announces Third Quarter Financial Results and Provides Company Update
CHF Solutions, Inc. (Nasdaq: CHFS), a medical device company focused on developing, manufacturing and commercializing a clinically proven solution for diuretic-resistant patients suffering from fluid overload, announced today its results for the...
Nov 04, 2019 09:19 am ET
CHF Solutions, Inc. Announces Pricing of Registered Direct Offering Priced At-the-Market
CHF Solutions, Inc. (CHF Solutions or the Company) (NASDAQ:CHFS) today announced the pricing of a registered direct offering of 1,219,076 shares of its common stock (or common equivalents) at a price to the public of $1.12 per share, for gross...
Nov 01, 2019 08:00 am ET
CHF Solutions, Inc. Announces Sales Force Realignment To Increase Focus On Cardiac Surgery And Eventually Pediatrics
CHF Solutions, Inc. (Nasdaq: CHFS), a medical device company focused on developing, manufacturing and commercializing a clinically proven solution for diuretic-resistant patients suffering from fluid overload, announced a sales force realignment to...
Oct 29, 2019 08:00 am ET
CHF Solutions, Inc. To Announce Third Quarter 2019 Financial Results and Corporate Update on November 5, 2019
CHF Solutions, Inc. (NASDAQ: CHFS) announces today that its third quarter 2019 financial results will be released on Tuesday, November 5, 2019. The company will host a conference call and webcast at 9:00 AM ET that morning, during which management...
Oct 24, 2019 08:00 am ET
Abington Hospital Begins a 344 Patient Retrospective Clinical Study to Analyze Experience with CHF Solutions’ Aquadex FlexFlow® System
CHF Solutions (Nasdaq: CHFS) today announced that investigators at Abington Hospital-Jefferson Health in Abington, Pennsylvania are conducting a retrospective analysis of their experience using the company’s Aquadex FlexFlow System in heart failure...
Oct 23, 2019 09:10 am ET
CHF Solutions, Inc. Announces Pricing of Registered Direct Offering
CHF Solutions, Inc. (CHF Solutions or the Company) (NASDAQ:CHFS) today announced the pricing of a registered direct offering of 575,830 shares of its common stock at a price to the public of $1.15 per share, for gross proceeds of approximately...
Oct 17, 2019 08:30 am ET
CHF Solutions to Exhibit at The American College of Chest Physicians (CHEST) Annual Meeting 2019
CHF Solutions, Inc. (Nasdaq:CHFS) today announced that it will be exhibiting at the American College of Chest Physicians’ (CHEST) Annual Meeting 2019, on October 21-23, 2019. The conference will be held at the Ernest N. Morial Convention Center in...
Oct 10, 2019 08:00 am ET
CHF Solutions Announces that James A. Haley Veterans’ Hospital Receives Final Approval To Initiate Heart Failure Outpatient Study utilizing Aquadex FlexFlow® System
CHF Solutions (Nasdaq: CHFS), today announced that James A. Haley Veterans’ Hospital and Clinics (JAHVH), located in Tampa, Florida, has received Institutional Review Board approval to initiate an outpatient study using the Aquadex FlexFlow system...
Oct 08, 2019 08:00 am ET
CHF Solutions, Inc. to Present at the MicroCap Rodeo Investor Conference on October 15, 2019
CHF Solutions, Inc. (Nasdaq: CHFS) today announced that John Erb, the company’s chairman and CEO, will be presenting and meeting with investors at the first annual MicroCap Rodeo investor conference on October 15, 2019 at 8:35 AM CT in meeting room...
Oct 03, 2019 08:30 am ET
CHF Solutions To Exhibit at Upcoming Heart Failure Conferences
CHF Solutions, Inc. (Nasdaq:CHFS) today announced that it will be exhibiting at two Heart Failure conferences during October: Mount Sinai Advanced Innovations in Heart FailureNew York Academy of MedicineNew York CityOctober 10, 2019 For...
Oct 01, 2019 08:00 am ET
CHF Solutions submits 510(k) application for Use of Aquadex FlexFlow® System with Pediatric Patients
CHF Solutions, Inc. (Nasdaq:CHFS) today announced that it has submitted an application to the FDA requesting for 510(k) clearance of the Aquadex FlexFlow system to include pediatric patients who weigh 20kg or more. Subject to FDA review, the...
Sep 24, 2019 08:00 am ET
Multi-Center, Retrospective Study Evaluates Use of Ultrafiltration Therapy with Aquadex FlexFlow® System in Pediatric Patients
CHF Solutions, Inc. (Nasdaq:CHFS) today announced the publication of a multi-center, retrospective study in the Clinical Journal of the American Society of Nephrology1 evaluating the use of hemofiltration and ultrafiltration therapy with the...
Sep 19, 2019 08:00 am ET
CHF Solutions, Inc. to Present at the Ladenburg Thalmann’s 2019 Healthcare Conference on September 24, 2019
CHF Solutions, Inc. (Nasdaq:CHFS) today announced that Claudia Napal Drayton, the company’s CFO, will be presenting and meeting with investors at the 2019 Landenburg Thalmann’s 2019 Healthcare Conference on September 24, 2019 at 4:00 PM ET in Track...
Sep 17, 2019 08:00 am ET
CHF Solutions, Inc. to Host a Call with Investigator Panel to Discuss Results of a Study Involving Use of Aquadex FlexFlow® in Pediatric Patients on September 25, 2019
CHF Solutions, Inc. (NASDAQ: CHFS) announced today that it will host a conference call and webcast at 1:00 PM ET on Wednesday, September 25, 2019 to discuss the results of a multicenter, retrospective study involving pediatric patients who need...
Sep 10, 2019 08:00 am ET
CHF Solutions, Inc. to Exhibit at the 23rd Annual Scientific Meeting of the Heart Failure Society of America
CHF Solutions, Inc. (Nasdaq:CHFS) today announced it would be exhibiting at the 23rd Annual Scientific Meeting of the Heart Failure Society of America from September 14-16, 2019. The conference is being held at the Pennsylvania Convention Center...
Sep 06, 2019 04:15 pm ET
CHF Solutions, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
CHF Solutions, Inc. (NASDAQ: CHFS), today announced that, on September 3, 2019, the independent directors approved four equity awards under CHF Solution’s New-Hire Equity Incentive Plan, as material inducements to four individuals entering into...
Sep 04, 2019 08:00 am ET
CHF Solutions, Inc. Appoints World-Renowned Heart Failure Cardiologist, Maria Rosa Costanzo, M.D. to Company’s Board of Directors
CHF Solutions, Inc. (Nasdaq:CHFS) today announced that Maria Rosa Costanzo, M.D. has been appointed to the Company's Board of Directors. Dr. Costanzo is the medical director, Heart Failure Research, at Advocate Heart Institute, and the medical...
Aug 16, 2019 04:30 pm ET
CHF Solutions, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
CHF Solutions, Inc. (NASDAQ: CHFS), today announced that, on August 15, 2019, the independent directors approved nine equity awards under CHF Solution’s New-Hire Equity Incentive Plan, as material inducements to nine individuals entering into...
Aug 08, 2019 07:00 am ET
New Publication Highlights Transient Increases in Creatinine or Tubular Injury Markers in Heart Failure Patients Should Not Dissuade Use of Ultrafiltration
CHF Solutions, Inc. (Nasdaq: CHFS) announced today the publication of a study in Circulation Heart Failure1 highlighting the benefits of decongestion outweigh concerns from previous studies that showed a rise in creatinine levels or tubular injury...
Aug 06, 2019 08:00 am ET
CHF Solutions, Inc. Announces 53 Percent Increase in Revenues for Second Quarter 2019 Over Previous Year and 38 Percent Increase from Q1 2019
CHF Solutions, Inc. (Nasdaq: CHFS), a medical device company focused on developing, manufacturing and commercializing a clinically proven alternative to diuretics for the treatment of fluid overload,  announced today its results for the second...
Jul 30, 2019 08:30 am ET
CHF Solutions, Inc. To Announce Second Quarter 2019 Financial Results and Corporate Update on August 6, 2019
CHF Solutions, Inc. (NASDAQ: CHFS) announces today that its second quarter 2019 financial results will be released on Tuesday, August 6, 2019. The company will host a conference call and webcast at 9:00 AM ET that morning, during which management...
Jul 16, 2019 08:30 am ET
Texas Health Resources Launches Ultrafiltration Therapy Using CHF Solutions’ Aquadex FlexFlow® System
CHF Solutions (Nasdaq: CHFS) today announced that the Texas Health Resources hospital system has initiated the offering of ultrafiltration therapy using the company’s Aquadex FlexFlow system. “Heart failure continues to be an increasingly urgent...
Jun 25, 2019 08:30 am ET
CHF Solutions To Exhibit At the American Association of Heart Failure Nurses 15th Annual Meeting
CHF Solutions (Nasdaq: CHFS), today announced it will be exhibiting at the 15th Annual Meeting of the American Association of Heart Failure Nurses (AAHFN) June 27-29, 2019 at the JW Marriott Austin in Austin, Texas. The company will be exhibiting...
Jun 13, 2019 08:30 am ET
CHF Solutions Sponsored AATS Session on Post-Cardiac Surgery, Highlighting Benefits of Using the Aquadex FlexFlow® System Following Cardiac Surgery
CHF Solutions (Nasdaq: CHFS), today announced highlights from the sponsored session from the American Association for Thoracic Surgery Annual Meeting moderated by Daniel Beckles, M.D., Ph.D. of United Health Services Hospitals in Binghamton, N.Y....
May 29, 2019 04:30 pm ET
CHF Solutions, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
CHF Solutions, Inc. (NASDAQ: CHFS), today announced that, on May 23, 2019, the independent directors approved five equity awards under CHF Solution’s New-Hire Equity Incentive Plan, as material inducements to five individuals entering into...
May 15, 2019 08:30 am ET
CHF Solutions Announces Launch of Ultrafiltration Therapy Using Aquadex FlexFlow® System at Beebe Healthcare
CHF Solutions (Nasdaq: CHFS) today announces that Sussex County, Delaware-based health system, Beebe Healthcare, has initiated offering ultrafiltration therapy using the company’s Aquadex FlexFlow system. “As heart failure and other conditions...
May 07, 2019 08:00 am ET
CHF Solutions, Inc. Announces 17 Percent Increase in Revenues for First Quarter 2019 Over Previous Year and Provides Company Update
CHF Solutions, Inc. (Nasdaq: CHFS) announced today its results for the first quarter ended March 31, 2019, which included the following highlights: Revenue for first quarter ended March 31, 2019 was $1.2 million, an increase of 17 percent compared...
May 06, 2019 04:30 pm ET
CHF Solutions Welcomes Industry Veteran Nestor Jaramillo as Chief Commercial Officer
CHF Solutions (Nasdaq: CHFS) today announces it has hired Nestor Jaramillo, Jr. as its new chief commercial officer, effective May 7, 2019. “Nestor has been a key player in medical device commercialization for more than 20 years and has led...
Apr 30, 2019 08:30 am ET
CHF Solutions, Inc. To Announce First Quarter 2019 Financial Results on May 7, 2019
CHF Solutions, Inc. (NASDAQ: CHFS) announces today that its first quarter 2019 financial results will be released on Tuesday, May 7, 2019. The company will host a conference call and webcast at 9:00 AM ET that morning, during which management will...
Apr 23, 2019 08:30 am ET
CHF Solutions to Sponsor CT Theatre Session, “Personalized Medicine: Improving Clinical Outcomes with Novel Fluid Management Strategies” Moderated by Renowned Cardiothoracic Surgeon Daniel Beckles, M.
CHF Solutions (Nasdaq: CHFS), today announced it will be sponsoring a CT Theatre Session at the American Association for Thoracic Surgery Annual Meeting on Monday, May 6, 2019, 1:00-1:30 pm at the Metro Toronto Convention Center. The panel titled,...
Apr 16, 2019 08:30 am ET
CHF Solutions Announces Launch of Ultrafiltration Program at Heart Hospital at Saint Francis
CHF Solutions (Nasdaq: CHFS) today announced that Heart Hospital at Saint Francis has launched an ultrafiltration program using the Aquadex FlexFlow® system to assist in the management of fluid overload in patients following cardiac surgery and in...
Apr 09, 2019 08:30 am ET
CHF Solutions Announces Launch of Ultrafiltration Program at Oklahoma Heart Institute
CHF Solutions (Nasdaq: CHFS) today announced that Oklahoma Heart Institute in Tulsa, Oklahoma, has launched an ultrafiltration program using the Aquadex FlexFlow® system to assist in the management of fluid overload in patients following cardiac...
Apr 03, 2019 08:30 am ET
CHF Solutions Submits Patent Application for Pediatric Use of Aquadex FlexFlow® System
CHF Solutions (Nasdaq: CHFS) today announced the submission of a method of use application to the United States Patent and Trademark Administration for pediatric use of its Aquadex Flex Flow System. Illustrative claims in the application include...
Mar 28, 2019 08:30 am ET
CHF Solutions to Exhibit at The International Society for Heart and Lung Transplantation 2019 Annual Meeting and Scientific Sessions
CHF Solutions (Nasdaq: CHFS), today announced it will be exhibiting at the 2019 Annual Meeting and Scientific Sessions of the International Society for Heart and Lung Transplantation (ISHLT) on April 3-6, 2019 at the Lowes Meeting Complex in...
Mar 26, 2019 08:30 am ET
Newly Published Article Demonstrates Ultrafiltration with CHF Solutions’ Aquadex FlexFlow® System Reduces Hospital Costs by Lowering 90-Day Re-admissions and Durations of Stay in Heart Failure Patient
CHF Solutions (Nasdaq: CHFS), today announced the publication of “Ultrafiltration vs. Diuretics for Treatment of Fluid Overload in Patients with Heart Failure:  A  Hospital Cost Analysis” in the Journal of Medical Economics showing that the use of...
Mar 12, 2019 04:05 pm ET
CHF Solutions, Inc. Announces Closing of $12.42 Million Underwritten Public Offering and Full Exercise of Over-Allotment Option
CHF Solutions, Inc. (NASDAQ:CHFS) today announced the closing of an underwritten public offering of units for gross proceeds of $12.42 million, which includes the full exercise of the underwriter's over-allotment option to purchase additional...
Mar 08, 2019 08:30 am ET
CHF Solutions, Inc. Announces Pricing of $10.8 Million Underwritten Public Offering
CHF Solutions, Inc. (NASDAQ:CHFS) today announced the pricing of an underwritten public offering of units for gross proceeds of approximately $10.8 million prior to deducting underwriting discounts and commissions and offering expenses payable by...
Mar 01, 2019 08:30 am ET
CHF Solutions, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
CHF Solutions, Inc. (NASDAQ: CHFS), today announced that effective February 25, 2019, the independent directors approved five equity awards under CHF Solution’s New-Hire Equity Incentive Plan, as material inducements to five individuals entering...
Feb 20, 2019 08:30 am ET
CHF Solutions, Inc. Announces 80% Revenue Growth for its Fourth Quarter and Provides Company Update
CHF Solutions, Inc. (Nasdaq: CHFS) announced today its results for the fourth quarter and year ended December 31, 2018, which included the following highlights: Revenue for the fourth quarter ended December 31,...
Feb 19, 2019 08:30 am ET
CHF Solutions Enters the South American Market with a Distribution Agreement with Bragenix LTDA in Brazil
CHF Solutions (Nasdaq: CHFS), today announced the initiation of a distribution agreement in the Brazilian market with Bragenix, LTDA.  This agreement expands the company’s worldwide sales outreach into South America by entering the largest market...
Feb 13, 2019 08:30 am ET
CHF Solutions, Inc. To Announce Fourth Quarter and Year-End 2018 Financial Results on February 20, 2019
CHF Solutions, Inc. (NASDAQ: CHFS) announces today that its fourth quarter and year-end 2018 financial results will be released on Wednesday, February 20, 2019. The company will host a conference call and webcast at 9:00 AM ET that morning, during...
Jan 31, 2019 08:30 am ET
CHF Solutions Announces Distribution Agreement in India
CHF Solutions (Nasdaq: CHFS), today announced the initiation of a distribution agreement in the Indian market with Wayinia Lifesciences.  This agreement expands the company’s sales outreach in Asia, while opening new access to one of the larger...
Jan 24, 2019 08:30 am ET
CHF Solutions Sponsors Breakfast Symposium on Ultrafiltration Featuring Renowned Cardiologist Daniel Beckles, M.D., Ph.D., at Society of Thoracic Surgeons 55th Annual Meeting
CHF Solutions (Nasdaq: CHFS), today announced it will be sponsoring a breakfast symposium at the Society of Thoracic Surgeons Annual Meeting, featuring Daniel Beckles, M.D., Ph.D., on Monday, January 28, 2019, at the Marriott Marquis in San Diego,...
Jan 16, 2019 08:30 am ET
CHF Solutions Expands Intellectual Property Portfolio with Two New Patent Filings for Innovations to Aquadex FlexFlow® System
CHF Solutions (Nasdaq: CHFS) today announced the filing of two new patent applications with the United States Patent and Trademark Office (USPTO) designed to deepen the company’s intellectual property protection for its Aquadex FlexFlow system....
Dec 05, 2018 08:30 am ET
CHF Solutions to Exhibit at Heart Failure University
CHF Solutions (Nasdaq: CHFS), today announced that it will be exhibiting at Heart Failure University from December 7-9, 2018 at the Los Angeles Airport Marriott, Los Angeles, Calif. “Heart Failure University is a unique venue as cardiology fellows...
Nov 15, 2018 08:30 am ET
CHF Solutions Launches Educational Webinar Discussing the Benefits of Aquadex FlexFlow® Therapy Following Cardiovascular Surgery with Cardiovascular Surgeon, Daniel Beckles, M.D., Ph.D.
CHF Solutions, Inc. (Nasdaq: CHFS), today announces the launch of its new educational webinar featuring Daniel Beckles, M.D., Ph.D., director of Minimally Invasive Cardiothoracic Surgery at UHS Heart and Vascular Institute, Vestal, N.Y.  The...
Nov 09, 2018 04:15 pm ET
CHF Solutions, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
CHF Solutions, Inc. (NASDAQ: CHFS) today announced that on November 8, 2018, the independent directors approved four equity awards under CHF Solution’s New-Hire Equity Incentive Plan, as material inducements to four individuals entering into...
Nov 08, 2018 09:00 am ET
CHF Solutions to Release Educational Webinar Highlighting Use of Aquadex FlexFlow® System in Post-Cardiovascular Surgery Featuring Noted Cardiovascular Surgeon, Daniel Beckles, MD, PhD
CHF Solutions, Inc. (Nasdaq: CHFS), today announced that it will release an educational webinar featuring the clinical use of the Aquadex FlexFlow system following cardiovascular surgery in patients who have failed diuretic therapy.  The webinar...
Nov 06, 2018 08:00 am ET
CHF Solutions, Inc. Announces 42% Revenue Growth for its Third Quarter and Provides Company Update
CHF Solutions, Inc. (NASDAQ: CHFS) announced today its third quarter results for the period ended September 30, 2018.  Highlights include: Revenue for third quarter ended September 30, 2018 increased 42 percent compared to the same period in...
Nov 01, 2018 08:30 am ET
CHF Solutions Initiates Strategic Collaboration with Daxor Corporation to Assist in the Management of Patients with Fluid Overload
CHF Solutions, Inc. (Nasdaq: CHFS) announced today that it has entered into a collaboration agreement with Daxor Corporation (NYSE:DXR) to explore potential synergies between the company’s Aquadex FlexFlow® System and Daxor’s BVA-100 Blood Volume...
Oct 30, 2018 08:30 am ET
CHF Solutions, Inc. To Announce Third Quarter Financial Results on November 6, 2018
CHF Solutions, Inc. (NASDAQ: CHFS) announces today that its third quarter 2018 financial results will be released on Tuesday, November 6, 2018. The company will host a conference call and webcast at 9:00 AM EST that morning, during which management...
Oct 24, 2018 08:30 am ET
CHF Solutions to Present at the Dawson James Securities 4th Annual Small Cap Growth Conference
CHF Solutions (Nasdaq: CHFS), today announced that Claudia Drayton, chief financial officer, will present and meet one-on-one with investors at the Dawson James Securities 4th Annual Small Cap Growth Conference on October 30, 2018. The company...
Oct 11, 2018 08:30 am ET
CHF Solutions Initiates Strategic Collaboration with NI Medical on Management of Fluid Overloaded Patients
CHF Solutions, Inc. (Nasdaq: CHFS) announced today that it has entered into a collaboration agreement with NI Medical to explore potential clinical synergies between the company’s Aquadex FlexFlow® System and NI Medical’s NICaS Hemodynamic...
Oct 03, 2018 08:30 am ET
CHF Solutions to Attend Southwest Nephrology Conference and Cardio Renal Metabolic Conference
CHF Solutions, Inc. (Nasdaq: CHFS) today announced that the company will be an exhibitor at the 19th Annual Southwest Nephrology Conference and 6th Annual Cardio Renal Metabolic Conference to be held jointly on October 5-6, 2018 at the Pointe...
Sep 25, 2018 08:30 am ET
CHF Solutions to Present at 2018 Ladenburg Thalmann Healthcare Conference October 2, 2018
CHF Solutions (Nasdaq: CHFS), today announced that John Erb, chairman and CEO will present at the 2018 Ladenburg Thalmann Healthcare Conference and meet one-on-one with investors.  The company will present on Tuesday, October 2, 2018 at The...
Sep 20, 2018 08:30 am ET
Recently Presented Data Demonstrate Benefits of CHF Solutions’ Aquadex FlexFlow® System in Managing Fluid Overload in Heart Failure Patients from the United Kingdom
CHF Solutions, Inc. (Nasdaq:CHFS) announced today results from a poster recently presented by a United Kingdom’s National Health Service hospital that demonstrated ultrafiltration provides a safe and effective alternative means of fluid removal in...
Sep 13, 2018 08:30 am ET
CHF Solutions Expands Commercial Focus of Fluid Overloaded Patients into the Post-Cardiovascular Surgery Market
CHF Solutions, Inc. (Nasdaq: CHFS), today announced that it is expanding its commercial focus into the post-cardiovascular surgery market, where, like in heart failure, patients often need treatment for fluid overload and have failed diuretic...
Sep 11, 2018 08:00 am ET
CHF Solutions, Inc. to Attend the 22nd Annual Scientific Meeting of the Heart Failure Society of America
CHF Solutions, Inc. (Nasdaq:CHFS) announced today it will be attending the 22nd Annual Scientific Meeting of the Heart Failure Society of America (HFSA) at the Gaylord Opryland Hotel and Convention Center in Nashville, Tenn. September 15-17, 2018....
Sep 05, 2018 08:30 am ET
CHF Solutions, Inc. Acquires Impedance Technology from Vasamed, Inc.
CHF Solutions, Inc. (Nasdaq:CHFS) announced today it has acquired the AcQtrac™ System technology from Vasamed, Inc. The AcQtrac System is a patented, non-invasive device designed to measure cardiac and hemodynamic parameters utilizing impedance...
Aug 23, 2018 08:30 am ET
CHF Solutions, Inc. Completes In-House Manufacturing Capabilities with Initiation of Catheter Production
CHF Solutions, Inc. (NASDAQ: CHFS), today announced it has now completed the transition of all manufacturing activities related to Aquadex FlexFlow® with the initiation of in-house catheter manufacturing at its facility in Eden Prairie, Minnesota....
Aug 21, 2018 08:30 am ET
CHF Solutions, Inc. Extends Reach in Asia with Distribution in Thailand
CHF Solutions, Inc. (Nasdaq: CHFS) announced today that the company received registration from FDA Thailand to allow the sale of Aquadex Flex Flow® in Thailand.  The product will be sold through the company’s current distributor in South-East Asia,...
Aug 17, 2018 04:05 pm ET
CHF Solutions, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
CHF Solutions, Inc. (NASDAQ: CHFS), today announced that on August 15, 2018, the independent directors approved seven equity awards under CHF Solution’s New-Hire Equity Incentive Plan, as material inducements to seven individuals entering into...
Aug 07, 2018 08:00 am ET
CHF Solutions, Inc. Announces 27% Revenue Growth for its Second Quarter and Provides Company Update
CHF Solutions, Inc. (NASDAQ: CHFS) announced today its second quarter results for the period ended June 30, 2018.  Highlights include: Revenue for second quarter ended June 30, 2018 increased 27 percent compared to the same period in 2017 and six...
Jul 31, 2018 09:20 am ET
CHF Solutions, Inc. To Announce Second Quarter Financial Results on August 7, 2018
CHF Solutions, Inc. (NASDAQ:CHFS) announces today that its second quarter 2018 financial results will be released on Tuesday, August 7, 2018. The company will host a conference call and webcast at 9:00 AM EDT that morning, during which management...
Jul 25, 2018 08:30 am ET
Department of Veterans Affairs Awards a $6.5 million Blanket Purchase Agreement to CHF Solutions to Supply Aquadex FlexFlow System for Outpatient Services in Tampa, Fla.
As previously disclosed on its website, FedBizOps.gov, the United States Department of Veterans Affairs has awarded CHF Solutions, Inc. (Nasdaq:CHFS) a blanket purchase agreement from the United States Department of Veterans Affairs to supply...
Jul 12, 2018 08:30 am ET
CHF Solutions, Inc. Enters the German Market
CHF Solutions, Inc. (NASDAQ:CHFS), today announces it has entered into the German market by expanding a relationship with HSC-Medical, GmbH, a business solutions resource based in Germany. HSC-Medical will serve as a fulfillment house and...
Jul 03, 2018 12:23 pm ET
CHF Solutions, Inc. Announces Closing of Common Stock Offering
CHF Solutions, Inc. (NASDAQ:CHFS) today announced the closing of its previously-announced underwritten public offering of 2,547,169 shares of its common stock at a price to the public of $2.12 per share, for gross proceeds of $5.4 million,...
Jun 29, 2018 09:27 am ET
CHF Solutions, Inc. Announces Pricing of Common Stock Offering
CHF Solutions, Inc. (NASDAQ:CHFS) today announced the pricing of an underwritten public offering of 2,214,930 shares of its common stock at a price to the public of $2.12 per share, for gross proceeds of approximately $4.7 million prior to...
Jun 20, 2018 08:30 am ET
CHF Solutions, Inc. Hires Additional Field Sales Representatives and Expands Territories
CHF Solutions, Inc. (NASDAQ:CHFS), today announces it has expanded its commercial sales team with the addition of three seasoned field sales representatives, growing its sales outreach from 10 to 13 territories. The new sales representatives joined...
Jun 06, 2018 08:30 am ET
CHF Solutions to Exhibit at the 14th Annual American Association of Heart Failure Nurses Meeting
CHF Solutions (Nasdaq:CHFS), today announces that it will be exhibiting at the 14th Annual American Association of Heart Failure Nurses Meeting from June 28-30, 2018 in Chicago. The company will be featuring the Aquadex FlexFlow System and...
May 30, 2018 08:30 am ET
CHF Solutions to Present at the LD Micro 8th Annual Invitational on June 4, 2018
CHF Solutions, Inc. (Nasdaq:CHFS), today announces that Claudia Drayton, chief financial officer of CHF Solutions, will be a featured presenter at the LD Micro Invitational Conference on Monday June 4, 2018 at 2:30 PM Pacific Time. The conference...
May 24, 2018 08:30 am ET
New Data Presented at ISPOR Shows Ultrafiltration Therapy Demonstrates a Cost Savings of $3,975 Per Patient at 90 Days
CHF Solutions, Inc. (Nasdaq:CHFS) announced today that a cost analysis1 from the hospital perspective showed substantial cost savings at 90 days when using an ultrafiltration system versus diuretic therapy.  This research was presented in a poster...
May 18, 2018 05:31 pm ET
CHF Solutions, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
CHF Solutions, Inc. (NASDAQ:CHFS), today announced that on May 16, 2018, the independent directors approved six equity awards under CHF Solution’s New-Hire Equity Incentive Plan, as material inducements to six individuals entering into employment...
May 17, 2018 08:30 am ET
CHF Solutions to Exhibit at Heart Failure 2018 in Vienna, Austria
CHF Solutions (Nasdaq:CHFS), today announces that it will be exhibiting at the Heart Failure Meeting from May 26-29, 2018 in Vienna, Austria. This annual congress is organized by the Heart Failure Association of the European Society of Cardiology...
May 14, 2018 08:30 am ET
CHF Solutions, Inc. Fulfills First Commercial Orders for Italy and Asia
CHF Solutions, Inc. (Nasdaq:CHFS) announced today that it has received and fulfilled first commercial orders from its distributor in Italy, TRX Italy, S.r.l. The company has also fulfilled orders previously received from its distributor in Asia,...
May 08, 2018 08:00 am ET
CHF Solutions, Inc. Announces 25 Percent Increase in Revenues for First Quarter 2018 Over Previous Quarter and Provides Company Update
CHF Solutions, Inc. (Nasdaq:CHFS) announced today its results for the first quarter ended March 31, 2018, which included the following highlights: Revenue for first quarter ended March 31, 2018 increased 24.8 percent compared to the previous...
May 01, 2018 08:30 am ET
CHF Solutions, Inc. To Announce First Quarter 2018 Financial Results May 8, 2018
EDEN PRAIRIE, Minn., May 01, 2018 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (Nasdaq:CHFS) announces today that its first quarter financial results will be released on Tuesday, May 8, 2018. The company will host a conference call and webcast at 9:00 AM...
Apr 26, 2018 08:30 am ET
CHF Solutions, Inc. to Present Healthcare Cost Analysis of Aquadex FlexFlow System Compared to Standard of Care in Heart Failure Patients with Fluid Overload at ISPOR Conference
EDEN PRAIRIE, Minn., April 26, 2018 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (Nasdaq:CHFS) announces today that new comparative data between the company’s Aquadex FlexFlow system and pharmaceutical therapy will be presented in a poster session at the International Society...
Apr 17, 2018 08:30 am ET
CHF Solutions, Inc. Expands European Distribution with New Agreement in Italy
EDEN PRAIRIE, Minn., April 17, 2018 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (Nasdaq:CHFS) announced today further expansion into the European markets with the initiation of a new distribution agreement with TRX Italy, S.r.I. to distribute the company’s Aquadex FlexFlow...
Apr 12, 2018 08:30 am ET
CHF Solutions, Inc. Expands Operations into Hong Kong; Receives First Commercial Orders for Both Hong Kong and Singapore
EDEN PRAIRIE, Minn., April 12, 2018 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (Nasdaq:CHFS) announced today its commercial expansion into the Hong Kong market through its Asia distributor, Transmedic.  Further, Transmedic has confirmed its first commercial orders for both Singapore...
Apr 10, 2018 08:30 am ET
Recently Published CARRESS-HF Per Protocol Analysis Demonstrates Greater Fluid Reduction in Heart Failure Patients Using CHF Solutions’ Aquadex FlexFlow System
EDEN PRAIRIE, Minn., April 10, 2018 (GLOBE NEWSWIRE) -- A recently published study in the European Journal of Heart Failure highlighted a per protocol analysis of the CARRESS-HF study, which demonstrated that ultrafiltration with the Aquadex Flex Flow...
Apr 05, 2018 08:30 am ET
CHF Solutions, Inc. Initiates Distribution Agreement in Spain
EDEN PRAIRIE, Minn., April 05, 2018 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (NASDAQ:CHFS) announced today the initiation of a new distribution agreement with Dimedix Surgical to distribute the company’s Aquadex FlexFlow System in Spain.
Apr 02, 2018 08:30 am ET
CHF Solutions to Present at The MicroCap Conference on April 9, 2018
EDEN PRAIRIE, Minn., April 02, 2018 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq:CHFS), today announces that it will present at The MicroCap Conference on April 9, 2018.
Mar 29, 2018 08:30 am ET
CHF Solutions, Inc. Begins New Educational Program, “Facing the Facts About Fluid Overload” to Demonstrate the Need for Aquadex Therapy
EDEN PRAIRIE, Minn., March 29, 2018 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (Nasdaq: CHFS) announced today the launch of a new educational program, “Facing the Facts About Fluid Overload,” designed to inform providers about an alternative ultrafiltration therapy for...
Mar 20, 2018 08:00 am ET
Mar 19, 2018 08:30 am ET
CHF Solutions, Inc. Launches Enhanced Educational Materials to Expand Utilization of the Aquadex FlexFlow System
EDEN PRAIRIE, Minn., March 19, 2018 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (Nasdaq:CHFS) announced today the launch of a suite of new educational and sales support materials designed to expand utilization of the company’s Aquadex FlexFlow system and enhance...
Mar 13, 2018 08:30 am ET
CHF Solutions, Inc. To Announce Fourth Quarter and Year End Financial Results March 20, 2018
EDEN PRAIRIE, Minn., March 13, 2018 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (Nasdaq:CHFS) announces today that its fourth quarter and year-end 2017 financial results will be released on Tuesday, March 20, 2018. The company will host a conference call and...
Mar 12, 2018 08:30 am ET
Industry Veteran Carrie Powers Joins CHF Solutions, Inc. as Vice President of Marketing
EDEN PRAIRIE, Minn., March 12, 2018 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (NASDAQ:CHFS), today announces the appointment of Carrie Powers, RN, as vice president of marketing.
Mar 09, 2018 08:30 am ET
CHF Solutions, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
EDEN PRAIRIE, Minn., March 09, 2018 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (NASDAQ:CHFS), today announced that on March 5, 2018, it issued an equity award previously approved by the independent directors CHF Solution’s New-Hire Equity Incentive Plan, as...
Mar 07, 2018 08:30 am ET
CHF Solutions to Exhibit at the 67th Annual Scientific Sessions of the American College of Cardiology 
EDEN PRAIRIE, Minn., March 07, 2018 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq:CHFS), today announces that it will be exhibiting at the 67th Annual Scientific Sessions of the American College of Cardiology (ACC) from March 10-12 in Orlando, Florida.
Mar 06, 2018 08:30 am ET
CHF Solutions to Attend the 30th Annual Roth Conference
EDEN PRAIRIE, Minn., March 06, 2018 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq:CHFS), today announces that it will attend the 30th Annual Roth Conference and meet one-on-one with investors. 
Feb 23, 2018 08:30 am ET
CHF Solutions, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
EDEN PRAIRIE, Minn., Feb. 23, 2018 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (NASDAQ:CHFS), today announced that on February 22, 2018, the independent directors approved equity awards under CHF Solution’s New-Hire Equity Incentive Plan, as material inducements to nine...
Feb 22, 2018 08:30 am ET
CHF Solutions, Inc. Enhances Commercial Team with the Establishment of a Field Clinical Organization and New Sales Territories
EDEN PRAIRIE, Minn., Feb. 22, 2018 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (NASDAQ:CHFS), today announces it has expanded its commercial operations team with the addition of three new field clinical specialists to help optimize use of its Aquadex FlexFlow...
Feb 07, 2018 08:30 am ET
CHF Solutions, Inc. To Present at 20th Annual BIO CEO & Investor Conference
EDEN PRAIRIE, Minn., Feb. 07, 2018 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (NASDAQ:CHFS), today announces its CEO, John Erb, will be a featured presenter and will be available for one-on-one meetings with investors at the 20th Annual BIO CEO...
Feb 06, 2018 08:30 am ET
CHF Solutions, Inc. Strengthens Sales Force with Senior Director of US Sales
EDEN PRAIRIE, Minn., Feb. 06, 2018 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (NASDAQ:CHFS), today announces the appointment of Richard E. Roberts as its senior director of U.S. sales, who will lead the US sales force for the company’s Aquadex...
Jan 31, 2018 08:30 am ET
CHF Solutions, Inc. Commences In-House Manufacturing of Aquadex FlexFlow Console and Blood Circuits
EDEN PRAIRIE, Minn., Jan. 31, 2018 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (NASDAQ:CHFS), today announced it has completed the first production units of both its Aquadex FlexFlow® console capital equipment and blood circuit disposable products from its manufacturing facility...
Jan 24, 2018 08:30 am ET
CHF Solutions, Inc. Appoints Vitaliy Epshteyn Vice President of Operations and Engineering
EDEN PRAIRIE, Minn., Jan. 24, 2018 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (NASDAQ:CHFS), today announces the appointment of Vitaliy Epshteyn (age 40) as its vice president of operations and engineering.
Jan 19, 2018 08:00 am ET
CHF Solutions, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
EDEN PRAIRIE, Minn., Jan. 19, 2018 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (NASDAQ:CHFS), today announced that on January 17, 2018, the independent directors approved equity awards under CHF Solutions’ New-Hire Equity Incentive Plan, as material inducements to six...
Jan 12, 2018 08:00 am ET
CHF Solutions, Inc. to Present at NobleCon 14 on January 29th, 2018
EDEN PRAIRIE, Minn., Jan. 12, 2018 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (NASDAQ:CHFS) announced today that John Erb, Chief Executive Officer, will be a featured presenter at NobleCon14, Noble Capital Markets’ Fourteenth Annual Investor Conference, on January 29th...
Dec 13, 2017 08:00 am ET
CHF Solutions Signs International Distribution and Services Agreement with Singapore-based TRANSMEDIC Pte Ltd.
EDEN PRAIRIE, Minn., Dec. 13, 2017 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (NASDAQ:CHFS) announced today that it has entered into an international distribution agreement with Singapore-based TRANSMEDIC Pte Ltd to market and support CHF Solutions’ Aquadex FlexFlow® System in...
Nov 30, 2017 07:15 am ET
CHF Solutions, Inc. to Present at the LD Micro 10th Annual Main Event on December 5, 2017
EDEN PRAIRIE, Minn., Nov. 30, 2017 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (NASDAQ:CHFS) announced today that Claudia Drayton, Chief Financial Officer will be a featured presenter at the LD Micro 10th Annual Main Event on Tuesday, December 5,...
Nov 27, 2017 05:15 pm ET
CHF Solutions, Inc. Announces Closing of $18.0 Million Underwritten Public Offering
EDEN PRAIRIE, Minn., Nov. 27, 2017 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (NASDAQ:CHFS) announced today the closing of an underwritten public offering of Series F convertible preferred stock, together with warrants, for gross proceeds of $18.0 million, prior...
Nov 22, 2017 08:30 am ET
CHF Solutions, Inc. Announces Pricing of $18.0 Million Underwritten Public Offering
EDEN PRAIRIE, Minn., Nov. 22, 2017 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (NASDAQ:CHFS) announced today the pricing of an underwritten public offering of Series F convertible preferred stock, together with warrants, for gross proceeds of $18.0 million, prior to...
Nov 07, 2017 08:00 am ET
CHF Solutions, Inc. Announces Ultrafiltration Meta-Analysis Highlighting Significant Reduction in Heart Failure Readmissions at 90 Days
EDEN PRAIRIE, Minn., Nov. 07, 2017 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (NASDAQ:CHFS) announced today that the Heart Failure Reviews released a comprehensive meta-analysis1 evaluating the role of ultrafiltration (UF) in reducing hospital readmissions in acute decompensated heart...
Oct 12, 2017 12:55 pm ET
CHF Solutions Announces 1 for 20 Reverse Split Ratio
EDEN PRAIRIE, Minn., Oct. 12, 2017 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (NASDAQ:CHFS) announced today a 1-for-20 reverse split of its common stock, effective at 5:00 pm Eastern time today.  Beginning tomorrow, October 13, 2017, the Company’s common stock will trade on The Nasdaq Capital Market on a split adjusted basis....
Sep 28, 2017 08:00 am ET
CHF Solutions Initiates International Distribution with UK-Based APC Cardiovascular Ltd.
EDEN PRAIRIE, Minn., Sept. 28, 2017 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (NASDAQ:CHFS) announced today that it is initiating international distribution of its products by entering into a distribution agreement with APC Cardiovascular Ltd., a distributor based in the United Kingdom. APC Cardiovascular will market CHF Solutions’ Aquadex FlexFlow® System and will serve as CHF Solutions authorized service provider in the United Kingdom....
Sep 21, 2017 08:15 am ET
CHF Solutions to Present at the Ladenburg Thalmann 2017 Healthcare Conference on September 26, 2017
EDEN PRAIRIE, Minn., Sept. 21, 2017 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (NASDAQ:CHFS) announced today that John Erb, CEO, will be a featured presenter at the Ladenburg Thalmann 2017 Healthcare Conference at the Sofitel Hotel in New York City on September 26, 2017 at 1:30pm eastern time. Interested parties can view the Company’s presentation on its Investor tab at https://www.chf-solutions.com....
Aug 24, 2017 04:05 pm ET
CHF Solutions to Exhibit at the ESC Congress 2017 in Barcelona, Spain, August 26-30, 2017
EDEN PRAIRIE, Minn., Aug. 24, 2017 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (NASDAQ:CHFS) announced today it will be exhibiting at the European Society of Cardiology, ESC Congress 2017 meeting in Barcelona, Spain, from August 26 through August 30, 2017 in the Emerging Technology Showcase Area at booth F170. The ESC Congress is the world's largest cardiovascular congress with over 500 experts’ sessions and more than 4,500 abstracts contributing to the advancement of cardiovascular medicine worldwide. The Company will be meeting with both cardiology key opinion leaders and potential product dis...
Aug 03, 2017 08:00 am ET
CHF Solutions Commences Manufacturing Transition of Aquadex FlexFlow® System to its Minnesota Facility
EDEN PRAIRIE, Minn., Aug. 03, 2017 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (NASDAQ:CHFS) announced today that it has begun the process of transitioning the manufacturing of the Aquadex FlexFlow System from an indirect subsidiary of Baxter International, Inc. (NYSE:BAX), a global leader in the hospital products and dialysis markets, to CHF Solutions’ facility in Eden Prairie, Minnesota.  The initial step, the transfer of the manufacturing assets, was completed last week.  These manufacturing assets were acquired from Baxter as part of the Aquadex acquisition that was completed on August 5, 20...
Aug 01, 2017 08:00 am ET
CHF Solutions, Inc. to Announce Second Quarter 2017 Results on August 8, 2017
EDEN PRAIRIE, Minn., Aug. 01, 2017 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (NASDAQ:CHFS) announced today that its second quarter 2017 results will be released on Tuesday, August 8, 2017, before the open of the stock market. The company will host a conference call and webcast at 9:00 AM ET that morning, during which management will discuss the company’s financial results and provide a general business overview....
Jun 06, 2017 05:15 pm ET
CHF Solutions, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
EDEN PRAIRIE, Minn., June 06, 2017 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (NASDAQ:CHFS), today announced that on May 25, 2017, the independent directors approved two equity awards under CHF Solution’s New-Hire Equity Incentive Plan, as material inducements to two individuals entering into employment with the Company.  The equity awards were approved in accordance with NASDAQ Listing Rule 5635(c)(4), which also requires a public announcement of equity awards that are not made under a stockholder approved equity plan....

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.